Todd Skrinar

Todd Skrinar_headshot 5-13-14Todd Skrinar a leader in EY’s Life Sciences practice, Todd brings 22+ years experience applying technology for competitive advantage with both large and emerging organizations. Todd focuses on helping Life Sciences and Healthcare organizations realize the benefits highly visible business operations.  Todd has a wide range of Life Sciences client experience including work with Amgen, Genentech, Merck, MedImmune, Actelion, Bio-Rad, Ortho Biotech and Solvay Pharmaceuticals. He has also worked extensively in the High Tech and Consumer Goods industries. Todd has a broad business process background including Marketing, Sales, Distribution and Logistics, and Business Analytics. His technical areas of expertise are ERP, CRM, Business Intelligence, web and collaboration.

Most recently at IBM Global Business Services, Todd was the Global Relationship Partner for Amgen and led the West Region of the Life Sciences practice.  During his six years at IBM, Todd also played Strategy & Transformation Partner roles at Genentech, Novartis, Actelion and Bio-Rad.

Prior to IBM, Todd led the Health and Life Sciences consulting practice at Unisys where he led multiple analytics-driven transformation programs that spanned marketing, commercial operations, manufacturing and global supply chain management.

Before being recruited to start the Health and Life Sciences practice at Unisys, Todd played leadership roles at Collaborex and Riverton, both venture-funded technology start-ups focused on innovation opportunities in business-to-business e-commerce.  Prior these roles, Todd was a Senior Manager at Price Waterhouse and PWC for seven years after beginning his career at Andersen Consulting.

Mr. Skrinar holds a Bachelor of Science degree in Business Management from Boston University and an MBA from Emory.

Todd has published on the topic of business analytics in life sciences. He is also a widely cited speaker on topics related to business analytics, supply chain visibility, brand protection and drug safety.

Todd has also been active in collaborations aimed at establishing industry standards for improved information sharing across the Health and Life Sciences ecosystem.  These included a role as a Special Advisor to the Health and Life Sciences Business Action Group of EPCGlobal and Work Group Lead for an industry assessment and position statement to FDA regarding future adoption patterns for track and trace technology in the Health and Life Sciences industry.

Improving Compliance with Data Science

Life sciences organizations face significant challenges with regard to risk management. One solution to minimizing risk may be better “big data” management, including forensic data analytics to mine mountains of data for indicators of fraud or corruption. Competitively speaking, there is immense power in big data...though that must be done with an eye on risk.

Read more